カタログ製品コード : C-E0065h
ELISA kit for Interleukin-1 receptor type 1
24T | ¥75,600 | (¥3,150/T) (税別) |
48T | ¥86,500 | (¥1,802/T) (税別) |
96T | ¥102,800 | (¥1,071/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-E0065h
ELISA kit for Interleukin-1 receptor type 1
24T | ¥75,600 | (¥3,150/T) (税別) |
48T | ¥86,500 | (¥1,802/T) (税別) |
96T | ¥102,800 | (¥1,071/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
EIAab | IL1R1 | Human | 0.156-10 ng/mL | 100 μl | 血清、血漿、尿、組織ホモジネート、細胞培養上清等 |
■保存方法 :
一時保存の場合
TMB:4℃
試薬類:バイアルに記載の温度
長期保存の場合
-20℃
■測定原理 :
The microtiter plate provided in this kit has been pre-coated with an antibody specific to IL-1R-1. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated polyclonal antibody preparation specific for IL-1R-1 and Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain IL-1R-1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of IL-1R-1 in the samples is then determined by comparing the O.D. of the samples to the standard curve.
■構成内容 :
Reagent | Quantity |
Assay plate | 1 |
Standard | 2 |
Sample Diluent | 1 × 20ml |
Assay Diluent A | 1 × 10ml |
Assay Diluent B | 1 × 10ml |
Detection Reagent A | 1 × 120μl |
Detection Reagent B | 1 × 120μl |
Wash Buffer(25 x concentrate) | 1 × 30ml |
Substrate | 1 × 10ml |
Stop Solution | 1 × 10ml |
Plate sealer for 96 wells | 5 |
Instruction | 1 |
■キーワード :
Homo sapiens,Human,Interleukin-1 receptor type 1,IL-1R-1,IL-1RT-1,IL-1RT1,CD121 antigen-like family member A,Interleukin-1 receptor alpha,IL-1R-alpha,Interleukin-1 receptor type I,p80,IL1R1,IL1R,IL1RA,
■ターゲット情報 :
Receptor for interleukin-1 alpha (IL-1A), beta (IL-1B), and interleukin-1 receptor antagonist protein (IL-1RA). Binding to the agonist leads to the activation of NF-kappa-B. Signaling involves formation of a ternary complex containing IL1RAP, TOLLIP, MYD88, and IRAK1 or IRAK2.